Stem Cells: a Journey Into a New Frontier

Total Page:16

File Type:pdf, Size:1020Kb

Stem Cells: a Journey Into a New Frontier SCIENCE WATCH J Am Soc Nephrol 12: 1773–1780, 2001 Stem Cells: A Journey into a New Frontier BRYON E. PETERSEN and NAOHIRO TERADA Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, and Stem Cell Program, University of Florida, Gainesville, Florida. Stem cells are cells that are capable of self-renewal and are embryonic origin first isolated from the inner cell mass of multipotent, meaning that they can differentiate into many developing mouse blastocysts (1,2). The distinguished features specific cell types. For a long time, “stem cell” had been a of ES cells are their capacity to be maintained in an undiffer- concept in mammalian biology but not a reality that could be entiated state indefinitely in culture and their potential to seen, touched, and expanded in vitro, until murine embryonic develop into every cell type of the body. Indeed, ES cells were stem cell culture was established in 1981. Through recent the only nontransformed mammalian stem cells that could be progress made in adult stem cell research, we now can isolate propagated continuously in vitro until recently, when culture various stem/progenitor cells derived from adult tissues, such methods of various adult stem cells were established. as neural stem cells, vascular endothelial progenitor cells, and Self-renewing, totipotent ES cells may provide a virtually hepatic oval cells. Of the many adult stem cells described in the unlimited donor source for transplantation and tissue genera- literature (hematopoietic, neural, hepatic, dermal, pancreatic, tion in vitro in the future. Mouse ES cell–derived hematopoi- and intestinal), it once was thought that these cells could etic precursors, cardiomyocytes, neural precursors, or insulin- differentiate only into the cell type from which they originated. producing cells, have been transplanted successfully into It now seems that the adult stem cell is more plastic, versatile, recipient animals. Because human ES cells (and embryonic and capable of becoming many different types of cells, e.g., germ cells) were isolated and shown recently to have a similar blood to brain/liver, brain to blood, liver to blood. These new potential for differentiation as the mouse ES cells (3,4), these findings give the once lonely adult stem cell a new lease on life techniques may be applied in the near future to patients with and perhaps a better chance in enabling both investigators and various diseases. Ultimately, in vitro–generated tissues from clinicians to fight life-threatening human diseases. Recent stem human ES cells may take the place at least in part of organ cell–based cell therapies have been shown to be successful in transplantation. ES-derived tissue-specific cells also will be an animal models for various diseases, such as Parkinson’s dis- ideal source for drug efficacy and toxicity testing (5). ease and insulin-dependent diabetes mellitus. In the coming Counterbalancing the promise of ES cells are serious ethical decade, the focus of research will be stem cell–based cell concerns for the use of human ES cells because it requires therapy (or a combination of cell and gene therapy techniques). fertilized human eggs to establish them. Because of recent In this article, we discuss the present status and the future of advances in methods that establish various stem cells from stem cell research via two major categories: embryonic stem adult tissues, enthusiasm for the direct application of human (ES) cells and adult stem cells. Self-renewal is discussed, ES cells clinically, once extremely high at the close of the 20th mostly from a point of view of gene regulation in the ES cell century, seems to be waning gradually. However, the signifi- and from a point of view of the microenvironment in the adult cance of studies in the ES cell as a prototype of pluripotent stem cell. In addition, the pluripotency of stem cells is ad- stem cells will go unchanged. The mechanism underlying dressed. Finally, we refer to the controversies arising in stem self-renewal activity of stem cells has been studied in depth cell research and the future applications of stem cells in using ES cells as described below. In terms of clinical appli- medicine. cation, the methods developed for generation of tissue-specific cells from ES cells would be applied easily to adult stem cells. ES Cells Hence, ES cells will remain important as a research tool in the Not many people would argue against the statement that study of mammalian development (see Figure 1). establishment of pluripotent murine ES cell culture is one of the great achievements in mammalian cell and developmental Self-Renewal of Pluripotent ES Cells biology. ES cells are continuously growing stem cell lines of Self-renewal is one of the most important characteristics of stem cells. Its molecular mechanism has been studied inten- sively in ES cells but is incompletely understood. Mouse ES Received April 16, 2001. Accepted May 4, 2001. cells can proliferate in vitro in an undifferentiated, pluripotent Correspondence to Dr. Bryon E. Petersen, P.O. Box 100275, Department of state on a feeder layer of mouse embryonic fibroblast cells or Pathology, University of Florida, Gainesville, FL 32610. Phone: 352-392- 6261; Fax: 352-392-6249; E-mail: [email protected] in a medium containing leukemia inhibitory factor (LIF) (6). 1046-6673/1208-1773 LIF belongs to the interleukin-6 (IL-6) cytokine family, which Journal of the American Society of Nephrology includes IL-6, IL-11, oncostatin M, ciliary neurotropic factor, Copyright © 2001 by the American Society of Nephrology and cardiotropin-1 (7). The effect of LIF is mediated through a 1774 Journal of the American Society of Nephrology J Am Soc Nephrol 12: 1773–1780, 2001 Figure 1. Promise of embryonic stem (ES) cells. Self-renewable ES cells (mouse or human) can differentiate into multiple lineages in vitro. This in vitro differentiation system has been used to study gene regulation in mammal development and roles of genes in specific tissues. Furthermore, ES cell–derived tissues are now expected for cell transplantation therapy, tissue engineering, and drug efficacy/toxicity tests. Counterbalancing the promise of ES cells are ethical concerns for the use of human ES cells because it requires fertilized human eggs to establish them. cell surface receptor (LIFR␤) and gp130, a common receptor trophectodermal-like differentiation of the cells, respectively. subunit of the IL-6 cytokine family. LIF binds with LIFR␤, Although Oct3/4-deficient mouse embryos develop to the blas- which then forms a high-affinity heterodimer complex with tocyst stage, the inner cell mass cells are not pluripotent but gp130. Among the signals transduced by the LIFR complex, restricted to differentiation along the extraembryonic tropho- activation of STAT3 was determined to be indispensable for blast lineage (14). These studies indicate that Oct3/4 is an the maintenance of undifferentiated ES cells (8–10). Expres- essential factor for maintenance of undifferentiated ES cells. sion of a dominant negative mutant of STAT3 abrogated self- Oct3/4 seems not to be a direct target of STAT3 (9). The renewal of ES cells and induced differentiation in the presence STAT3 pathway and the Oct3/4 pathway rather are considered of LIF (8). Furthermore, activation of STAT3 by forced dimer- to be two separate pathways, both of which are working ization of the molecule was sufficient for the self-renewal of coordinately for self-renewal of ES cells (13). ES cells in the absence of LIF (9). Because STAT3 is a Maintenance of telomere length is another feature observed transcription factor, self-renewal of ES cells likely is main- and required in self-renewal of stem cells. Both mouse and tained by the molecule(s) of which expression is regulated human ES cells have prolonged telomeres and high telomerase directly or indirectly by STAT3. It should be noted that primate activity. The molecular mechanism by which ES cells maintain ES cells, including human ES cells, differentiate or die in the telomere length, however, is unknown. It is interesting that absence of fibroblast feeder layers, even in the presence of LIF recent studies have revealed that telomere shortening is not a (3,11). The molecular basis of undifferentiating factors remains major reason for cell senescence in rodent cells, whereas it is unknown in human ES cells. It also is unclear whether human the major limiting factor in survival of human cells (15,16). ES cells require STAT3 activation for self-renewal. Oxidative stress or other factors may play more critical roles in Oct3/4 is a POU-domain transcription factor expressed ex- senescence of primary rodent cells. In this sense, mouse ES clusively in early embryonic cells and germ cells (12). Both cells should have a feature to escape from this senescence mouse and human ES cells highly express Oct3/4 when they mechanism as well. are maintained undifferentiated and lose expression when dif- ferentiated. It was demonstrated that expression of the appro- In Vitro Differentiation of ES Cells priate amount of Oct3/4 was critical for maintenance of undif- The most rigorous test of the developmental potential of ferentiated murine ES cells (13). According to the study, mouse ES cells is their ability to contribute to all cell lineages, increase and decrease in Oct3/4 resulted in mesodermal- and including the germ line of chimeric animals. This ability, in J Am Soc Nephrol 12: 1773–1780, 2001 Stem Cells 1775 conjunction with effective homologous recombination of DNA (35). Furthermore, in combination with the techniques to purify in ES cells, enabled us to generate knockout mice. In addition, tissue-specific cells described above, we can determine the when injected into immunocompromised animals, both murine function of genes in a specific tissue solely by in vitro assay and human ES cells form teratomas composed of multiple (19,30,36).
Recommended publications
  • The Act of Controlling Adult Stem Cell Dynamics: Insights from Animal Models
    biomolecules Review The Act of Controlling Adult Stem Cell Dynamics: Insights from Animal Models Meera Krishnan 1, Sahil Kumar 1, Luis Johnson Kangale 2,3 , Eric Ghigo 3,4 and Prasad Abnave 1,* 1 Regional Centre for Biotechnology, NCR Biotech Science Cluster, 3rd Milestone, Gurgaon-Faridabad Ex-pressway, Faridabad 121001, India; [email protected] (M.K.); [email protected] (S.K.) 2 IRD, AP-HM, SSA, VITROME, Aix-Marseille University, 13385 Marseille, France; [email protected] 3 Institut Hospitalo Universitaire Méditerranée Infection, 13385 Marseille, France; [email protected] 4 TechnoJouvence, 13385 Marseille, France * Correspondence: [email protected] Abstract: Adult stem cells (ASCs) are the undifferentiated cells that possess self-renewal and differ- entiation abilities. They are present in all major organ systems of the body and are uniquely reserved there during development for tissue maintenance during homeostasis, injury, and infection. They do so by promptly modulating the dynamics of proliferation, differentiation, survival, and migration. Any imbalance in these processes may result in regeneration failure or developing cancer. Hence, the dynamics of these various behaviors of ASCs need to always be precisely controlled. Several genetic and epigenetic factors have been demonstrated to be involved in tightly regulating the proliferation, differentiation, and self-renewal of ASCs. Understanding these mechanisms is of great importance, given the role of stem cells in regenerative medicine. Investigations on various animal models have played a significant part in enriching our knowledge and giving In Vivo in-sight into such ASCs regulatory mechanisms. In this review, we have discussed the recent In Vivo studies demonstrating the role of various genetic factors in regulating dynamics of different ASCs viz.
    [Show full text]
  • Epigenetic Metabolites License Stem Cell States
    CHAPTER SIX Epigenetic metabolites license stem cell states Logeshwaran Somasundarama,b,†, Shiri Levya,b,†, Abdiasis M. Husseina,b, Devon D. Ehnesa,b, Julie Mathieub,c, Hannele Ruohola-Bakera,b,∗ aDepartment of Biochemistry, University of Washington, Seattle, WA, United States bInstitute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, United States cDepartment of Comparative Medicine, University of Washington, Seattle, WA, United States ∗ Corresponding author: e-mail address: [email protected] Contents 1. Introduction 210 2. Stem cell energetics 210 3. Metabolism of quiescent stem cells 212 3.1 Adult stem cells 212 3.2 Pluripotent stem cell quiescence, diapause 216 4. Metabolism of active stem cells 217 4.1 Metabolism after fertilization 217 4.2 Metabolism of pre-implantation and post-implantation pluripotent stem cells 218 4.3 Metabolism of actively cycling adult stem cells: MSC as case-study 220 5. HIF, the master regulator of metabolism 222 6. Epigenetic signatures and epigenetic metabolites 224 6.1 Epigenetic signatures of naïve and primed pluripotent stem cells 224 6.2 Epigenetic signatures of adult stem cells 227 6.3 Epigenetic metabolites 228 7. Conclusion 229 Acknowledgments 230 References 230 Further reading 240 Abstract It has become clear during recent years that stem cells undergo metabolic remodeling during their activation process. While these metabolic switches take place in pluripotency as well as adult stem cell populations, the rules that govern the switch are not clear. † Equal contribution. # Current Topics in Developmental Biology, Volume 138 2020 Elsevier Inc. 209 ISSN 0070-2153 All rights reserved. https://doi.org/10.1016/bs.ctdb.2020.02.003 210 Logeshwaran Somasundaram et al.
    [Show full text]
  • Translational Applications of Adult Stem Cell-Derived Organoids Jarno Drost1,2,* and Hans Clevers1,2,3,‡
    © 2017. Published by The Company of Biologists Ltd | Development (2017) 144, 968-975 doi:10.1242/dev.140566 PRIMER Translational applications of adult stem cell-derived organoids Jarno Drost1,2,* and Hans Clevers1,2,3,‡ ABSTRACT of organotypic organoids from single Lgr5-positive ISCs (Sato Adult stem cells from a variety of organs can be expanded long- et al., 2009). These organoids contained all cell types of the ‘ ’ term in vitro as three-dimensional organotypic structures termed intestinal epithelium and were structured into proliferative crypt ‘ ’ organoids. These adult stem cell-derived organoids retain their organ and differentiated villus compartments, thereby retaining the identity and remain genetically stable over long periods of time. The architecture of the native intestine (Sato et al., 2009). In addition ability to grow organoids from patient-derived healthy and diseased to Wnt/R-spondin, epidermal growth factor (EGF) (Dignass and tissue allows for the study of organ development, tissue homeostasis Sturm, 2001), noggin (BMP inhibitor) (Haramis et al., 2004) and an and disease. In this Review, we discuss the generation of adult artificial laminin-rich extracellular matrix (provided by Matrigel) stem cell-derived organoid cultures and their applications in in vitro complemented the cocktail for successful in vitro propagation of disease modeling, personalized cancer therapy and regenerative mouse ISC-derived organoids (Sato et al., 2009). At the same time, medicine. Ootani et al. reported another Wnt-driven in vitro culture of ISCs (Ootani et al., 2009). In contrast to Sato et al., this culture was not KEY WORDS: Adult stem cells, Organoids, Disease modelling, based on defined growth factors.
    [Show full text]
  • Cancer from the Perspective of Stem Cells and Misappropriated Tissue Regeneration Mechanisms
    Leukemia (2018) 32:2519–2526 https://doi.org/10.1038/s41375-018-0294-7 REVIEW ARTICLE Corrected: Correction Stem cell biology Cancer from the perspective of stem cells and misappropriated tissue regeneration mechanisms 1,2 1 1 1,2 1 Mariusz Z. Ratajczak ● Kamila Bujko ● Aaron Mack ● Magda Kucia ● Janina Ratajczak Received: 8 September 2018 / Accepted: 17 September 2018 / Published online: 30 October 2018 © The Author(s) 2018. This article is published with open access Abstract Tumorigenesis can be considered as pathologically misappropriated tissue regeneration. In this review we will address some unresolved issues that support this concept. First, we will address the issue of the identity of cancer-initiating cells and the presence of cancer stem cells in growing tumors. We will also ask are there rare and distinct populations of cancer stem cells in established tumor cell lines, or are all of the cells cancer stem cells? Second, the most important clinical problem with cancer is its metastasis, and here a challenging question arises: by employing radio-chemotherapy for tumor treatment, do we unintentionally create a prometastatic microenvironment in collateral organs? Specifically, many factors upregulated in response to radio-chemotherapy-induced injury may attract highly migratory cancer cells that survived initial treatment. 1234567890();,: 1234567890();,: Third, what is the contribution of normal circulating stem cells to the growing malignancy? Do circulating normal stem cells recognize a tumor as a hypoxia-damaged tissue that needs
    [Show full text]
  • Adult Spinal Cord Stem Cells Generate Neurons After Transplantation in the Adult Dentate Gyrus
    The Journal of Neuroscience, December 1, 2000, 20(23):8727–8735 Adult Spinal Cord Stem Cells Generate Neurons after Transplantation in the Adult Dentate Gyrus Lamya S. Shihabuddin, Philip J. Horner, Jasodhara Ray, and Fred H. Gage The Salk Institute, Laboratory of Genetics, La Jolla, California 92037 The adult rat spinal cord contains cells that can proliferate and population of cells into the adult rat spinal cord resulted in their differentiate into astrocytes and oligodendroglia in situ. Using differentiation into glial cells only. However, after heterotopic clonal and subclonal analyses we demonstrate that, in contrast transplantation into the hippocampus, transplanted cells that to progenitors isolated from the adult mouse spinal cord with a integrated in the granular cell layer differentiated into cells char- combination of growth factors, progenitors isolated from the acteristic of this region, whereas engraftment into other hip- adult rat spinal cord using basic fibroblast growth factor alone pocampal regions resulted in the differentiation of cells with display stem cell properties as defined by their multipotentiality astroglial and oligodendroglial phenotypes. The data indicate and self-renewal. Clonal cultures derived from single founder that clonally expanded, multipotent adult progenitor cells from a cells generate neurons, astrocytes, and oligodendrocytes, con- non-neurogenic region are not lineage-restricted to their devel- firming the multipotent nature of the parent cell. Subcloning opmental origin but can generate region-specific neurons in vivo analysis showed that after serial passaging, recloning, and ex- when exposed to the appropriate environmental cues. pansion, these cells retained multipotentiality, indicating that they Key words: spinal cord; stem cells; FGF; transplantation; neu- are self-renewing.
    [Show full text]
  • Stem Cell Therapy and Gene Transfer for Regeneration
    Gene Therapy (2000) 7, 451–457 2000 Macmillan Publishers Ltd All rights reserved 0969-7128/00 $15.00 www.nature.com/gt MILLENNIUM REVIEW Stem cell therapy and gene transfer for regeneration T Asahara, C Kalka and JM Isner Cardiovascular Research and Medicine, St Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, MA, USA The committed stem and progenitor cells have been recently In this review, we discuss the promising gene therapy appli- isolated from various adult tissues, including hematopoietic cation of adult stem and progenitor cells in terms of mod- stem cell, neural stem cell, mesenchymal stem cell and ifying stem cell potency, altering organ property, accelerating endothelial progenitor cell. These adult stem cells have sev- regeneration and forming expressional organization. Gene eral advantages as compared with embryonic stem cells as Therapy (2000) 7, 451–457. their practical therapeutic application for tissue regeneration. Keywords: stem cell; gene therapy; regeneration; progenitor cell; differentiation Introduction poietic stem cells to blood cells. The determined stem cells differentiate into ‘committed progenitor cells’, which The availability of embryonic stem (ES) cell lines in mam- retain a limited capacity to replicate and phenotypic fate. malian species has greatly advanced the field of biologi- In the past decade, researchers have defined such com- cal research by enhancing our ability to manipulate the mitted stem or progenitor cells from various tissues, genome and by providing model systems to examine including bone marrow, peripheral blood, brain, liver cellular differentiation. ES cells, which are derived from and reproductive organs, in both adult animals and the inner mass of blastocysts or primordial germ cells, humans (Figure 1).
    [Show full text]
  • Progenitor Cell Therapy for the Treatment of Damaged Myocardium
    Progenitor Cell Therapy for the Treatment of Damaged Protocol Myocardium due to Ischemia (20218) Medical Benefit Effective Date: 01/01/11 Next Review Date: 07/22 Preauthorization No Review Dates: 09/10, 07/11, 07/12, 07/13, 07/14, 07/15, 07/16, 07/17, 07/18, 07/19, 07/20, 07/21 This protocol considers this test or procedure investigational. If the physician feels this service is medically necessary, preauthorization is recommended. The following protocol contains medical necessity criteria that apply for this service. The criteria are also applicable to services provided in the local Medicare Advantage operating area for those members, unless separate Medicare Advantage criteria are indicated. If the criteria are not met, reimbursement will be denied and the patient cannot be billed. Please note that payment for covered services is subject to eligibility and the limitations noted in the patient’s contract at the time the services are rendered. RELATED PROTOCOLS Orthopedic Applications of Stem Cell Therapy (Including Allograft and Bone Substitute Products Used With Autologous Bone Marrow) Stem Cell Therapy for Peripheral Arterial Disease Populations Interventions Comparators Outcomes Individuals: Interventions of interest Comparators of interest Relevant outcomes include: • With acute cardiac are: are: • Disease-specific survival ischemia • Progenitor cell therapy • Standard therapy • Morbid events • Functional outcomes • Quality of life • Hospitalizations Individuals: Interventions of interest Comparators of interest Relevant outcomes
    [Show full text]
  • Differential Contributions of Haematopoietic Stem Cells to Foetal and Adult Haematopoiesis: Insights from Functional Analysis of Transcriptional Regulators
    Oncogene (2007) 26, 6750–6765 & 2007 Nature Publishing Group All rights reserved 0950-9232/07 $30.00 www.nature.com/onc REVIEW Differential contributions of haematopoietic stem cells to foetal and adult haematopoiesis: insights from functional analysis of transcriptional regulators C Pina and T Enver MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK An increasing number of molecules have been identified ment and appropriate differentiation down the various as candidate regulators of stem cell fates through their lineages. involvement in leukaemia or via post-genomic gene dis- In the adult organism, HSC give rise to differentiated covery approaches.A full understanding of the function progeny following a series of relatively well-defined steps of these molecules requires (1) detailed knowledge of during the course of which cells lose proliferative the gene networks in which they participate and (2) an potential and multilineage differentiation capacity and appreciation of how these networks vary as cells progress progressively acquire characteristics of terminally differ- through the haematopoietic cell hierarchy.An additional entiated mature cells (reviewed in Kondo et al., 2003). layer of complexity is added by the occurrence of different As depicted in Figure 1, the more primitive cells in the haematopoietic cell hierarchies at different stages of haematopoietic differentiation hierarchy are long-term ontogeny.Beyond these issues of cell context dependence, repopulating HSC (LT-HSC),
    [Show full text]
  • Radial Glia Give Rise to Adult Neural Stem Cells in the Subventricular Zone
    Radial glia give rise to adult neural stem cells in the subventricular zone Florian T. Merkle*†, Anthony D. Tramontin*†, Jose´ Manuel Garcı´a-Verdugo‡, and Arturo Alvarez-Buylla*§ *Department of Neurological Surgery, Developmental and Stem Cell Biology Program, Box 0525, University of California, San Francisco, CA 94143; and ‡Instituto Cavanilles, Universidad de Valencia, 46100 Valencia, Spain Communicated by Fernando Nottebohm, The Rockefeller University, Millbrook, NY, October 22, 2004 (received for review September 1, 2004) Neural stem cells with the characteristics of astrocytes persist in the ventricle of postnatal day (P) 0 mice (29). We show that these subventricular zone (SVZ) of the juvenile and adult brain. These radial glial cells give rise to neurons, astrocytes, ependymal cells, cells generate large numbers of new neurons that migrate through and oligodendrocytes. More importantly, we show that these the rostral migratory stream to the olfactory bulb. The develop- neonatal radial glial cells give rise to the SVZ astrocytes that mental origin of adult neural stem cells is not known. Here, we maintain neurogenesis in the adult mammalian brain. This work describe a lox–Cre-based technique to specifically and permanently identifies the neonatal origin of adult SVZ neural stem cells. label a restricted population of striatal radial glia in newborn mice. Within the first few days after labeling, these radial glial cells gave Materials and Methods rise to neurons, oligodendrocytes, and astrocytes, including astro- Labeling of P0 Radial Glia by Striatal Adenovirus (Ad) Injection. All cytes in the SVZ. Remarkably, the rostral migratory stream con- protocols followed the guidelines of the Laboratory Animal tained labeled migratory neuroblasts at all ages examined, includ- Resource Center at the University of California, San Francisco.
    [Show full text]
  • Organoid Research Techniques
    2ïäÞëìæá5âðâÞïàå7âàåëæîòâð Cover Image: STEMCELL Technologies Copyright © 2019 Wiley Periodicals, Inc. All rights reserved. No part of this publication may be reproduced, stored or transmitted in any form or by any means without the prior permission in writing from the copyright holder. 2ïäÞëìæá5âðâÞïàå7âàåëæîòâð CONTENTS 3 INTRODUCTION 6 HISTORIC MILESTONES 12 IN PRACTICE 25 PROBLEMS & SOLUTIONS 27 WHAT’S NEXT 29 REFERENCES 31 FURTHER READING 2ïäÞëìæá5âðâÞïàå7âàåëæîòâð INTRODUCTION Ì, KHDUG DERXW RUJDQRLGV DQG WKRXJKW WKH\ PLJKW EH WKH SHUIHFW PRGHO WR VWXG\ DOO WKH SURFHVVHV WKDW ,ÊP LQWHUHVWHG LQÍ VD\V 7DPDUD =LHWHN 3ULQFLSDO ,QYHVWLJDWRU LQ WKH 1XWULWLRQ3K\VLRORJ\/DERUDWRU\DWWKH7HFKQLFDO8QLYHUVLW\ RI 0XQLFK %HIRUH XVLQJ RUJDQRLGV =LHWHNÊV JURXS ZRUNHG Eoth witK DQ LQ YLYRÈPLFHÈDQG LQ YLWURÈFHOO OLQHVÈ V\VWHP WR DQVZHU WKHLU UHVHDUFK TXHVWLRQV EXW WKH\ ZHUH RQ WKH KXQW IRU D V\VWHP WKDW FRPELQHG WKH DGYDQWDJHV RI ERWK 8VLQJ SULPDU\ FHOO FXOWXUHV ZDV DQ LPSURYHPHQW EXWEHFDXVHWKHFHOOVFRXOGQÊWEHSDVVDJHGLWZDVQRWDORQJ WHUP V\VWHP 6R =LHWHN XVHG RUJDQRLG PRGHO V\VWHPV WR EHWWHU XQGHUVWDQG LQWHVWLQDO QXWULHQW WUDQVSRUW DQG VHQVLQJ. In recent years, our cumulative understanding of organ physiology, development, and maintenance has resulted in the creation of three- GLPHQVLRQDO ' RUJDQRLGVÈFXOWXUHG'FHOOVWUXFWXUHVWKDWPRGHO features of organ function, composition, and development. Given that the RUJDQVRIRXUERG\RFFXS\'VSDFHRUJDQRLGVEHWWHUUHSUHVHQWWKHSK\VL- ological system than their two-dimensional culture counterparts for the purpose of organ
    [Show full text]
  • Stem Cells in Dermatology*
    Revista2Vol89ingles2_Layout 1 4/2/14 10:04 AM Página 286 286 REVIEW s Stem cells in dermatology* Karolyn Sassi Ogliari1 Daniel Marinowic1 Dario Eduardo Brum1 Fabrizio Loth1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20142530 Abstract: Preclinical and clinical research have shown that stem cell therapy could be a promising therapeutic option for many diseases in which current medical treatments do not achieve satisfying results or cure. This arti- cle describes stem cells sources and their therapeutic applications in dermatology today. Keywords: Adult stem cells; Dermatology; Hematopoietic stem cells; Stem cells; Regenerative medicine INTRODUCTION The current trend in medicine is to focus on two progenitor cell could generate cells that differed from major areas in which until recently there was not the original tissue (plasticity) and that they were much emphasis on: “prevention” of diseases and attracted to damaged tissues distant from their sur- “regenerative medicine”. The first provides the power roundings.2,3,4,5 Cells that presented this behavior were to change an individual’s destiny, preventing a dis- named stem cells. ease from occurring and increasing life expectancy, For a cell to be considered a stem cell, it has to while the second is an attempt to cure diseases for present three characteristics: self-renewal, i.e., asym- which modern medicine has yet no treatment avail- metric division resulting both in cells that are similar able. This article aims to briefly address regenerative to it, as well as specialized cells; the ability to regener- medicine, with the theme “stem cells”, from its dis- ate the tissue in which it is located, and plasticity, that covery to its current applications and future is the ability to generate other cell types, different prospects, describing the important role of skin cells from those of the original tissue.6 in this context.
    [Show full text]
  • Mathematical Model of Adult Stem Cell Regeneration with Cross-Talk Between Genetic and Epigenetic Regulation
    Mathematical model of adult stem cell regeneration with cross-talk between genetic and epigenetic regulation Jinzhi Leia, Simon A. Levinb,1, and Qing Niec aZhou Pei-Yuan Center for Applied Mathematics, Ministry of Education Key Laboratory of Bioinformatics, Tsinghua University, Beijing 100084, China; bDepartment of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544; and cDepartment of Mathematics, University of California, Irvine, CA 92697 Contributed by Simon A. Levin, January 7, 2014 (sent for review September 4, 2013) Adult stem cells, which exist throughout the body, multiply by cell are continuously cycling (9, 10). Each state is likely associated with division to replenish dying cells or to promote regeneration to repair a unique microenvironment (10, 11). Dormant and homeostatic damaged tissues. To perform these functions during the lifetime of HSCs are anchored in endosteal niches through interactions with organs or tissues, stem cells need to maintain their populations in a number of adhesion molecules expressed by both HSCs and a faithful distribution of their epigenetic states, which are suscepti- niche stromal cells (10, 12). Furthermore, injury-activated HSCs ble to stochastic fluctuations during each cell division, unexpected are located near sinusoidal vessels (the perivascular niche). In injury, and potential genetic mutations that occur during many cell response to the loss of hematopoietic cells, surviving dormant divisions. However, it remains unclear how the three processes of HSCs located
    [Show full text]